#1Parathyroid Hormone-Related Peptide (PTHrP)
PTHrP signaling regulates the hair follicle cycle; antagonism/knockout studies in mice alter anagen-telogen transitions, making the PTH/PTHrP axis a research target.
Best peptides by research goal
Thin but real evidence — mostly preclinical · 71 indexed studies
Best peptides for Hair Growth
Peptide research into hair growth focuses on follicle-cycling signaling (Wnt, activin/myostatin, PTH-family pathways) and dermal remodeling around the follicle. This is one of the thinnest-evidenced goal categories in the peptide space — most studies below are small, in vitro, or animal-model work, not human trials.
This is the thinnest-evidenced goal on the whole page. Every compound listed has fewer than 30 indexed studies, and most of that is preclinical follicle-culture or animal work rather than human trials. None of these compounds are FDA-approved hair-loss treatments, and the research volume here shouldn't be read as validating any specific product claim.
For educational and research purposes only. Nothing here is medical advice; these compounds are not approved for human consumption outside prescription use.
Most-researched peptides
Ranked by indexed studies#2Follistatin
Binds and neutralizes activin/myostatin signaling; activin inhibition shifts follicles from telogen (resting) toward anagen (growth) in animal follicle-cycling studies.
#3Copper peptides
Broader class of copper-binding peptides used topically; proposed to support follicle survival and extracellular-matrix remodeling relevant to scalp health.
#4GHK-Cu
Naturally occurring copper-binding tripeptide (Gly-His-Lys) that promotes dermal remodeling and has shown follicle growth-phase (anagen) stimulating effects in follicle-organ-culture and animal models.
#5PTD-DBM
A protein-transduction-domain-fused peptide designed to block DKK-1, a Wnt-pathway inhibitor implicated in androgenetic alopecia. The thinnest-evidenced compound on this list.
Frequently asked questions
It is the thinnest on the page. Every compound here has under 30 indexed studies, mostly follicle-culture or animal work. None are approved hair-loss treatments, unlike minoxidil or finasteride.
Study counts are PubMed search-result totals checked on September 24, 2026 and will change as new literature is indexed — the linked search always reflects the current live count. Vendor counts come from the products VialCheck currently tracks. This is a research index, not an endorsement of any compound, vendor, or use.